An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease

This study has been completed.

Study NCT00074542 Information provided by Tillotts Pharma AG

First Received: December 15, 2003 Last Updated: February 20, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	January 2005
Estimated Primary Completion Date:	No date given